Bambusa Therapeutics, Inc. (BBTX) income statement
BBTXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$16.00+0.45 (+2.89%)
Close on Nov 20, 2026Market cap –P/E –Yield –
Bambusa Therapeutics, Inc. financial ratios
Not enough reported data yet to compute ratios by period.
See a number that looks wrong?